An Integrated Approach to Diabetic Retinopathy Research

被引:76
作者
Gardner, Thomas W. [1 ,2 ]
Abcouwer, Steven F. [1 ,2 ,3 ]
Barber, Alistair J. [1 ,2 ]
Jackson, Gregory R. [1 ]
机构
[1] Penn State Coll Med, Dept Ophthalmol, Hershey, PA USA
[2] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA
[3] Penn State Coll Med, Dept Surg, Hershey, PA USA
关键词
RETINAL INSULIN-RECEPTOR; MICROGLIAL ACTIVATION; VASCULAR-PERMEABILITY; GLIAL REACTIVITY; LAYER THICKNESS; RAT; ABNORMALITIES; DYSFUNCTION; METABOLISM; EXPRESSION;
D O I
10.1001/archophthalmol.2010.362
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
This review discusses the pathophysiology of diabetic retinopathy related to direct effects of loss of insulin receptor action and metabolic dysregulation on the retina. The resulting sensory neuropathy can be diagnosed by structural and functional tests in patients with mild nonproliferative diabetic retinopathy. Research teams can collaborate to integrate ocular and systemic factors that impair vision and to design strategies to maintain retinal function in persons with diabetes mellitus. Evolving concepts may lead to inclusion of tests of retinal function in the detection of diabetic retinopathy and neuroprotective strategies to preserve vision for persons with diabetes. Arch Ophthalmol. 2011;129(2):230-235
引用
收藏
页码:230 / 235
页数:6
相关论文
共 46 条
[1]   Immunological mechanisms in the pathogenesis of diahetic retinopathy [J].
Adamis, Anthony P. ;
Berman, Adrienne J. .
SEMINARS IN IMMUNOPATHOLOGY, 2008, 30 (02) :65-84
[2]  
[Anonymous], DISCOVERY INSULIN CH
[3]   Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content - Vascular endothelial growth factor decreases occludin in retinal endothelial cells [J].
Antonetti, DA ;
Barber, AJ ;
Khin, S ;
Lieth, E ;
Tarbell, JM ;
Gardner, TW .
DIABETES, 1998, 47 (12) :1953-1959
[4]   Diabetic retinopathy - Seeing beyond glucose-induced microvascular disease [J].
Antonetti, David A. ;
Barber, Alistair J. ;
Bronson, Sarah K. ;
Freeman, Willard M. ;
Gardner, Thomas W. ;
Jefferson, Leonard S. ;
Kester, Mark ;
Kimball, Scot R. ;
Krady, J. Kyle ;
LaNoue, Kathryn F. ;
Norbury, Christopher C. ;
Quinn, Patrick G. ;
Sandirasegarane, Lakshman ;
Simpson, Ian A. .
DIABETES, 2006, 55 (09) :2401-2411
[5]  
Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561
[6]   The Ins2Akita mouse as a model of early retinal complications in diabetes [J].
Barber, AJ ;
Antonetti, DA ;
Kern, TS ;
Reiter, CEN ;
Soans, RS ;
Krady, JK ;
Levison, SW ;
Gardner, TW ;
Bronson, SK .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (06) :2210-2218
[7]   Neural apoptosis in the retina during experimental and human diabetes - Early onset and effect of insulin [J].
Barber, AJ ;
Lieth, E ;
Khin, SA ;
Antonetti, DA ;
Buchanan, AG ;
Gardner, TW .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :783-791
[8]  
BLOODWORTH JMB, 1962, DIABETES, V11, P1
[9]   EVIDENCE FOR EARLY IMPAIRMENT OF MACULAR FUNCTION WITH PATTERN ERG IN TYPE-I DIABETIC-PATIENTS [J].
CAPUTO, S ;
DILEO, MAS ;
FALSINI, B ;
GHIRLANDA, G ;
PORCIATTI, V ;
MINELLA, A ;
GRECO, AV .
DIABETES CARE, 1990, 13 (04) :412-418
[10]   Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium [J].
Csaky, Karl G. ;
Richman, Elaine A. ;
Ferris, Frederick L., III .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (02) :479-489